About Olympus BPH
Olympus BPH is a company based in Hadera (Israel) founded in 2007 was acquired by Olympus in February 2021. It operates as a HealthTech. Olympus BPH has raised $20 million across 2 funding rounds from investors including Olympus and Laborie Medical. Olympus BPH offers products and services including iTind Procedure.
- Headquarter Hadera, Israel
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Olympus Corporation Of The Americas
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Olympus BPH
Olympus BPH offers a comprehensive portfolio of products and services, including iTind Procedure.
A minimally invasive treatment for enlarged prostate issues.
Funding Insights of Olympus BPH
Olympus BPH has successfully raised a total of $20M across 2 strategic funding rounds. The most recent funding activity was a Unspecified round of $20 million completed in November 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Olympus BPH
Olympus BPH has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Olympus and Laborie Medical.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Manufacturer of imaging and surgical products
|
Locked | Locked | Locked | |
|
Medical products for female lower urinary tract dysfunctions are provided.
|
Locked | Locked | Locked |
Investor details for Olympus BPH
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Olympus BPH
Investment portfolio details for Olympus BPH
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Olympus BPH
Detailed financials for Olympus BPH
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Olympus Bph Comparisons
Peer comparison for Olympus BPH
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Olympus BPH
Detailed competitors of Olympus BPH
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Olympus Bph
Complete news archive for Olympus BPH
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Olympus BPH
Olympus BPH was founded in 2007 and raised its 1st funding round 9 years after it was founded.
Olympus BPH is headquartered in Hadera, Israel. It is registered at Hadera, Central District, Israel.
Olympus BPH is a funded company, having raised a total of $20M across 2 funding rounds to date.
Olympus BPH, under Olympus Corporation of the Americas, is dedicated to providing innovative solutions for benign prostatic hyperplasia (BPH) through the iTind procedure. This minimally invasive treatment is designed to address urinary symptoms caused by an enlarged prostate, offering rapid symptom relief while preserving sexual and urinary functions. The solution targets men aged 50 and older, serving the healthcare sector with a focus on urology.
Olympus BPH offers iTind Procedure.
Olympus BPH has 2 investors. Key investors include Olympus, and Laborie Medical.